HEADER ISOMERASE/IMMUNOSUPPRESSANT 07-JAN-94 2RMC TITLE CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH TITLE 2 IMMUNOSUPPRESSIVE DRUG CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE C; COMPND 3 CHAIN: A, C, E, G; COMPND 4 SYNONYM: ROTAMASE C, CYCLOPHILIN C; COMPND 5 EC: 5.2.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLOSPORIN A; COMPND 9 CHAIN: B, D, F, H; COMPND 10 SYNONYM: CICLOSPORIN, CICLOSPORINE; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_TAXID: 10090; SOURCE 4 MOL_ID: 2; SOURCE 5 SYNTHETIC: YES; SOURCE 6 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 7 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPPRESSANT, CYCLOPHILIN EXPDTA X-RAY DIFFRACTION AUTHOR H.KE,Y.ZHAO,F.LUO,I.WEISSMAN,J.FRIEDMAN REVDAT 8 06-DEC-23 2RMC 1 LINK REVDAT 7 27-SEP-23 2RMC 1 LINK SCALE ATOM REVDAT 6 01-NOV-17 2RMC 1 REMARK REVDAT 5 27-JUL-11 2RMC 1 ATOM HETATM REMARK SITE REVDAT 4 13-JUL-11 2RMC 1 VERSN REVDAT 3 24-FEB-09 2RMC 1 VERSN REVDAT 2 01-APR-03 2RMC 1 JRNL REVDAT 1 14-FEB-95 2RMC 0 JRNL AUTH H.KE,Y.ZHAO,F.LUO,I.WEISSMAN,J.FRIEDMAN JRNL TITL CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH JRNL TITL 2 IMMUNOSUPPRESSIVE DRUG CYCLOSPORIN A JRNL REF PROC.NATL.ACAD.SCI.USA V. 90 11850 1993 JRNL REFN ISSN 0027-8424 JRNL PMID 8265636 JRNL DOI 10.1073/PNAS.90.24.11850 REMARK 2 REMARK 2 RESOLUTION. 1.64 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.64 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 72159 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5928 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 401 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 2.680 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE SPACE GROUP IS P21 WITH THE ORIGIN REMARK 3 AT 1/4 OF X SO THAT THE SYMMETRY IS (X,Y,Z) AND (1/2-X, 1/2+Y,-X) REMARK 3 . REMARK 4 REMARK 4 2RMC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178570. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 998 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8428 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 993 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8479 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 984 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8553 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 994 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8459 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: B, D, F, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 31 CG CD CE NZ REMARK 470 ARG A 32 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 31 CG CD CE NZ REMARK 470 ARG C 32 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 31 CG CD CE NZ REMARK 470 ARG E 32 CG CD NE CZ NH1 NH2 REMARK 470 LYS G 31 CG CD CE NZ REMARK 470 ARG G 32 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 88 NE2 HIS A 88 CD2 -0.070 REMARK 500 HIS A 160 NE2 HIS A 160 CD2 -0.074 REMARK 500 HIS C 88 NE2 HIS C 88 CD2 -0.067 REMARK 500 HIS C 184 NE2 HIS C 184 CD2 -0.069 REMARK 500 HIS E 160 NE2 HIS E 160 CD2 -0.069 REMARK 500 HIS E 184 NE2 HIS E 184 CD2 -0.067 REMARK 500 HIS G 88 NE2 HIS G 88 CD2 -0.071 REMARK 500 HIS G 160 NE2 HIS G 160 CD2 -0.068 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 45 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 53 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 TRP A 131 CD1 - CG - CD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TRP A 131 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 TRP A 155 CD1 - CG - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 155 CE2 - CD2 - CG ANGL. DEV. = -5.4 DEGREES REMARK 500 TRP A 212 CD1 - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP A 212 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 ARG C 45 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG C 53 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 TRP C 131 CD1 - CG - CD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 TRP C 131 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 TRP C 155 CD1 - CG - CD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 TRP C 155 CE2 - CD2 - CG ANGL. DEV. = -5.3 DEGREES REMARK 500 TRP C 212 CD1 - CG - CD2 ANGL. DEV. = 6.6 DEGREES REMARK 500 TRP C 212 CE2 - CD2 - CG ANGL. DEV. = -6.0 DEGREES REMARK 500 ARG E 53 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 TRP E 131 CD1 - CG - CD2 ANGL. DEV. = 5.2 DEGREES REMARK 500 TRP E 131 CE2 - CD2 - CG ANGL. DEV. = -5.4 DEGREES REMARK 500 TRP E 155 CD1 - CG - CD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 TRP E 155 CE2 - CD2 - CG ANGL. DEV. = -5.8 DEGREES REMARK 500 TRP E 155 CG - CD2 - CE3 ANGL. DEV. = 5.6 DEGREES REMARK 500 TRP E 212 CD1 - CG - CD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 TRP E 212 CE2 - CD2 - CG ANGL. DEV. = -5.9 DEGREES REMARK 500 ARG G 53 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG G 89 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 TRP G 131 CD1 - CG - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP G 131 CE2 - CD2 - CG ANGL. DEV. = -5.1 DEGREES REMARK 500 TRP G 155 CD1 - CG - CD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP G 155 CE2 - CD2 - CG ANGL. DEV. = -5.4 DEGREES REMARK 500 TRP G 212 CD1 - CG - CD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 TRP G 212 CE2 - CD2 - CG ANGL. DEV. = -5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 94 -70.48 -128.69 REMARK 500 ARG A 104 18.65 58.65 REMARK 500 PHE A 163 -0.91 -148.03 REMARK 500 PRO A 210 -78.02 -23.96 REMARK 500 PHE C 94 -65.54 -128.18 REMARK 500 ARG C 104 18.64 56.93 REMARK 500 PHE C 163 -2.69 -146.30 REMARK 500 PRO C 210 -74.89 -42.80 REMARK 500 ASP C 211 79.54 -113.19 REMARK 500 MLE D 10 -168.47 -105.82 REMARK 500 PHE E 94 -70.80 -127.71 REMARK 500 ASN E 121 165.83 179.95 REMARK 500 PHE E 163 -3.73 -146.68 REMARK 500 PRO E 210 -82.85 -37.11 REMARK 500 PHE G 59 74.52 -100.15 REMARK 500 PHE G 94 -70.16 -131.40 REMARK 500 ASP G 211 67.85 62.90 REMARK 500 MLE H 10 -165.83 -106.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR E 127 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WIYH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1IKF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CTCLOSPORIN-FAB COMPLEX REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2ESL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN C COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A DBREF 2RMC A 31 212 UNP P30412 CYPC_MOUSE 31 212 DBREF 2RMC B 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2RMC C 31 212 UNP P30412 CYPC_MOUSE 31 212 DBREF 2RMC D 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2RMC E 31 212 UNP P30412 CYPC_MOUSE 31 212 DBREF 2RMC F 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2RMC G 31 212 UNP P30412 CYPC_MOUSE 31 212 DBREF 2RMC H 1 11 NOR NOR00033 NOR00033 1 11 SEQRES 1 A 182 LYS ARG GLY PRO SER VAL THR ASP LYS VAL PHE PHE ASP SEQRES 2 A 182 VAL ARG ILE GLY ASP LYS ASP VAL GLY ARG ILE VAL ILE SEQRES 3 A 182 GLY LEU PHE GLY ASN VAL VAL PRO LYS THR VAL GLU ASN SEQRES 4 A 182 PHE VAL ALA LEU ALA THR GLY GLU LYS GLY TYR GLY TYR SEQRES 5 A 182 LYS GLY SER ILE PHE HIS ARG VAL ILE LYS ASP PHE MET SEQRES 6 A 182 ILE GLN GLY GLY ASP PHE THR ALA ARG ASP GLY THR GLY SEQRES 7 A 182 GLY MET SER ILE TYR GLY GLU THR PHE PRO ASP GLU ASN SEQRES 8 A 182 PHE LYS LEU LYS HIS TYR GLY ILE GLY TRP VAL SER MET SEQRES 9 A 182 ALA ASN ALA GLY PRO ASP THR ASN GLY SER GLN PHE PHE SEQRES 10 A 182 ILE THR LEU THR LYS PRO THR TRP LEU ASP GLY LYS HIS SEQRES 11 A 182 VAL VAL PHE GLY LYS VAL LEU ASP GLY MET THR VAL VAL SEQRES 12 A 182 HIS SER ILE GLU LEU GLN ALA THR ASP GLY HIS ASP ARG SEQRES 13 A 182 PRO LEU THR ASP CYS THR ILE VAL ASN SER GLY LYS ILE SEQRES 14 A 182 ASP VAL LYS THR PRO PHE VAL VAL GLU VAL PRO ASP TRP SEQRES 1 B 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 C 182 LYS ARG GLY PRO SER VAL THR ASP LYS VAL PHE PHE ASP SEQRES 2 C 182 VAL ARG ILE GLY ASP LYS ASP VAL GLY ARG ILE VAL ILE SEQRES 3 C 182 GLY LEU PHE GLY ASN VAL VAL PRO LYS THR VAL GLU ASN SEQRES 4 C 182 PHE VAL ALA LEU ALA THR GLY GLU LYS GLY TYR GLY TYR SEQRES 5 C 182 LYS GLY SER ILE PHE HIS ARG VAL ILE LYS ASP PHE MET SEQRES 6 C 182 ILE GLN GLY GLY ASP PHE THR ALA ARG ASP GLY THR GLY SEQRES 7 C 182 GLY MET SER ILE TYR GLY GLU THR PHE PRO ASP GLU ASN SEQRES 8 C 182 PHE LYS LEU LYS HIS TYR GLY ILE GLY TRP VAL SER MET SEQRES 9 C 182 ALA ASN ALA GLY PRO ASP THR ASN GLY SER GLN PHE PHE SEQRES 10 C 182 ILE THR LEU THR LYS PRO THR TRP LEU ASP GLY LYS HIS SEQRES 11 C 182 VAL VAL PHE GLY LYS VAL LEU ASP GLY MET THR VAL VAL SEQRES 12 C 182 HIS SER ILE GLU LEU GLN ALA THR ASP GLY HIS ASP ARG SEQRES 13 C 182 PRO LEU THR ASP CYS THR ILE VAL ASN SER GLY LYS ILE SEQRES 14 C 182 ASP VAL LYS THR PRO PHE VAL VAL GLU VAL PRO ASP TRP SEQRES 1 D 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 E 182 LYS ARG GLY PRO SER VAL THR ASP LYS VAL PHE PHE ASP SEQRES 2 E 182 VAL ARG ILE GLY ASP LYS ASP VAL GLY ARG ILE VAL ILE SEQRES 3 E 182 GLY LEU PHE GLY ASN VAL VAL PRO LYS THR VAL GLU ASN SEQRES 4 E 182 PHE VAL ALA LEU ALA THR GLY GLU LYS GLY TYR GLY TYR SEQRES 5 E 182 LYS GLY SER ILE PHE HIS ARG VAL ILE LYS ASP PHE MET SEQRES 6 E 182 ILE GLN GLY GLY ASP PHE THR ALA ARG ASP GLY THR GLY SEQRES 7 E 182 GLY MET SER ILE TYR GLY GLU THR PHE PRO ASP GLU ASN SEQRES 8 E 182 PHE LYS LEU LYS HIS TYR GLY ILE GLY TRP VAL SER MET SEQRES 9 E 182 ALA ASN ALA GLY PRO ASP THR ASN GLY SER GLN PHE PHE SEQRES 10 E 182 ILE THR LEU THR LYS PRO THR TRP LEU ASP GLY LYS HIS SEQRES 11 E 182 VAL VAL PHE GLY LYS VAL LEU ASP GLY MET THR VAL VAL SEQRES 12 E 182 HIS SER ILE GLU LEU GLN ALA THR ASP GLY HIS ASP ARG SEQRES 13 E 182 PRO LEU THR ASP CYS THR ILE VAL ASN SER GLY LYS ILE SEQRES 14 E 182 ASP VAL LYS THR PRO PHE VAL VAL GLU VAL PRO ASP TRP SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 G 182 LYS ARG GLY PRO SER VAL THR ASP LYS VAL PHE PHE ASP SEQRES 2 G 182 VAL ARG ILE GLY ASP LYS ASP VAL GLY ARG ILE VAL ILE SEQRES 3 G 182 GLY LEU PHE GLY ASN VAL VAL PRO LYS THR VAL GLU ASN SEQRES 4 G 182 PHE VAL ALA LEU ALA THR GLY GLU LYS GLY TYR GLY TYR SEQRES 5 G 182 LYS GLY SER ILE PHE HIS ARG VAL ILE LYS ASP PHE MET SEQRES 6 G 182 ILE GLN GLY GLY ASP PHE THR ALA ARG ASP GLY THR GLY SEQRES 7 G 182 GLY MET SER ILE TYR GLY GLU THR PHE PRO ASP GLU ASN SEQRES 8 G 182 PHE LYS LEU LYS HIS TYR GLY ILE GLY TRP VAL SER MET SEQRES 9 G 182 ALA ASN ALA GLY PRO ASP THR ASN GLY SER GLN PHE PHE SEQRES 10 G 182 ILE THR LEU THR LYS PRO THR TRP LEU ASP GLY LYS HIS SEQRES 11 G 182 VAL VAL PHE GLY LYS VAL LEU ASP GLY MET THR VAL VAL SEQRES 12 G 182 HIS SER ILE GLU LEU GLN ALA THR ASP GLY HIS ASP ARG SEQRES 13 G 182 PRO LEU THR ASP CYS THR ILE VAL ASN SER GLY LYS ILE SEQRES 14 G 182 ASP VAL LYS THR PRO PHE VAL VAL GLU VAL PRO ASP TRP SEQRES 1 H 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL B 1 6 HET MLE B 2 9 HET MLE B 3 9 HET MVA B 4 8 HET BMT B 5 16 HET ABA B 6 7 HET SAR B 7 5 HET MLE B 8 9 HET MLE B 10 9 HET DAL D 1 6 HET MLE D 2 9 HET MLE D 3 9 HET MVA D 4 8 HET BMT D 5 16 HET ABA D 6 7 HET SAR D 7 5 HET MLE D 8 9 HET MLE D 10 9 HET DAL F 1 6 HET MLE F 2 9 HET MLE F 3 9 HET MVA F 4 8 HET BMT F 5 16 HET ABA F 6 7 HET SAR F 7 5 HET MLE F 8 9 HET MLE F 10 9 HET DAL H 1 6 HET MLE H 2 9 HET MLE H 3 9 HET MVA H 4 8 HET BMT H 5 16 HET ABA H 6 7 HET SAR H 7 5 HET MLE H 8 9 HET MLE H 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 2 DAL 4(C3 H7 N O2) FORMUL 2 MLE 16(C7 H15 N O2) FORMUL 2 MVA 4(C6 H13 N O2) FORMUL 2 BMT 4(C10 H19 N O3) FORMUL 2 ABA 4(C4 H9 N O2) FORMUL 2 SAR 4(C3 H7 N O2) FORMUL 9 HOH *401(H2 O) HELIX 1 1 VAL A 63 GLY A 76 1 14 HELIX 2 2 PRO A 153 ASP A 157 5 5 HELIX 3 3 GLY A 169 LEU A 178 1 10 HELIX 4 4 VAL C 63 GLY C 76 1 14 HELIX 5 5 PRO C 153 ASP C 157 5 5 HELIX 6 6 GLY C 169 LEU C 178 1 10 HELIX 7 7 VAL E 63 GLY E 76 1 14 HELIX 8 8 PRO E 153 ASP E 157 5 5 HELIX 9 9 GLY E 169 LEU E 178 1 10 HELIX 10 10 VAL G 63 GLY G 76 1 14 HELIX 11 11 PRO G 153 ASP G 157 5 5 HELIX 12 12 GLY G 169 LEU G 178 1 10 SHEET 1 AA 8 PHE A 87 ILE A 91 0 SHEET 2 AA 8 MET A 95 GLY A 98 -1 O MET A 95 N ILE A 91 SHEET 3 AA 8 PHE A 146 THR A 149 -1 O PHE A 146 N GLY A 98 SHEET 4 AA 8 TRP A 131 MET A 134 -1 O TRP A 131 N THR A 149 SHEET 5 AA 8 VAL A 162 ASP A 168 -1 N PHE A 163 O VAL A 132 SHEET 6 AA 8 LYS A 49 LEU A 58 -1 O VAL A 55 N LEU A 167 SHEET 7 AA 8 SER A 35 ILE A 46 -1 N THR A 37 O LEU A 58 SHEET 8 AA 8 CYS A 191 VAL A 206 -1 O THR A 192 N ARG A 45 SHEET 1 CA 8 PHE C 87 ILE C 91 0 SHEET 2 CA 8 MET C 95 GLY C 98 -1 O MET C 95 N ILE C 91 SHEET 3 CA 8 PHE C 146 THR C 149 -1 O PHE C 146 N GLY C 98 SHEET 4 CA 8 TRP C 131 MET C 134 -1 O TRP C 131 N THR C 149 SHEET 5 CA 8 VAL C 162 ASP C 168 -1 N PHE C 163 O VAL C 132 SHEET 6 CA 8 LYS C 49 LEU C 58 -1 O VAL C 55 N LEU C 167 SHEET 7 CA 8 SER C 35 ILE C 46 -1 N THR C 37 O LEU C 58 SHEET 8 CA 8 CYS C 191 VAL C 206 -1 O THR C 192 N ARG C 45 SHEET 1 EA 8 PHE E 87 ILE E 91 0 SHEET 2 EA 8 MET E 95 GLY E 98 -1 O MET E 95 N ILE E 91 SHEET 3 EA 8 PHE E 146 THR E 149 -1 O PHE E 146 N GLY E 98 SHEET 4 EA 8 TRP E 131 MET E 134 -1 O TRP E 131 N THR E 149 SHEET 5 EA 8 VAL E 162 ASP E 168 -1 N PHE E 163 O VAL E 132 SHEET 6 EA 8 LYS E 49 LEU E 58 -1 O VAL E 55 N LEU E 167 SHEET 7 EA 8 SER E 35 ILE E 46 -1 N THR E 37 O LEU E 58 SHEET 8 EA 8 CYS E 191 VAL E 206 -1 O THR E 192 N ARG E 45 SHEET 1 GA 8 PHE G 87 ILE G 91 0 SHEET 2 GA 8 MET G 95 GLY G 98 -1 O MET G 95 N ILE G 91 SHEET 3 GA 8 PHE G 146 THR G 149 -1 O PHE G 146 N GLY G 98 SHEET 4 GA 8 TRP G 131 MET G 134 -1 O TRP G 131 N THR G 149 SHEET 5 GA 8 VAL G 162 ASP G 168 -1 N PHE G 163 O VAL G 132 SHEET 6 GA 8 LYS G 49 LEU G 58 -1 O VAL G 55 N LEU G 167 SHEET 7 GA 8 SER G 35 ILE G 46 -1 N THR G 37 O LEU G 58 SHEET 8 GA 8 CYS G 191 VAL G 206 -1 O THR G 192 N ARG G 45 LINK C DAL B 1 N MLE B 2 1555 1555 1.34 LINK N DAL B 1 C ALA B 11 1555 1555 1.32 LINK C MLE B 2 N MLE B 3 1555 1555 1.34 LINK C MLE B 3 N MVA B 4 1555 1555 1.34 LINK C MVA B 4 N BMT B 5 1555 1555 1.35 LINK C BMT B 5 N ABA B 6 1555 1555 1.33 LINK C ABA B 6 N SAR B 7 1555 1555 1.34 LINK C SAR B 7 N MLE B 8 1555 1555 1.34 LINK C MLE B 8 N VAL B 9 1555 1555 1.33 LINK C VAL B 9 N MLE B 10 1555 1555 1.35 LINK C MLE B 10 N ALA B 11 1555 1555 1.33 LINK C DAL D 1 N MLE D 2 1555 1555 1.34 LINK N DAL D 1 C ALA D 11 1555 1555 1.33 LINK C MLE D 2 N MLE D 3 1555 1555 1.36 LINK C MLE D 3 N MVA D 4 1555 1555 1.35 LINK C MVA D 4 N BMT D 5 1555 1555 1.36 LINK C BMT D 5 N ABA D 6 1555 1555 1.33 LINK C ABA D 6 N SAR D 7 1555 1555 1.34 LINK C SAR D 7 N MLE D 8 1555 1555 1.34 LINK C MLE D 8 N VAL D 9 1555 1555 1.34 LINK C VAL D 9 N MLE D 10 1555 1555 1.34 LINK C MLE D 10 N ALA D 11 1555 1555 1.33 LINK C DAL F 1 N MLE F 2 1555 1555 1.35 LINK N DAL F 1 C ALA F 11 1555 1555 1.32 LINK C MLE F 2 N MLE F 3 1555 1555 1.34 LINK C MLE F 3 N MVA F 4 1555 1555 1.34 LINK C MVA F 4 N BMT F 5 1555 1555 1.35 LINK C BMT F 5 N ABA F 6 1555 1555 1.33 LINK C ABA F 6 N SAR F 7 1555 1555 1.33 LINK C SAR F 7 N MLE F 8 1555 1555 1.34 LINK C MLE F 8 N VAL F 9 1555 1555 1.33 LINK C VAL F 9 N MLE F 10 1555 1555 1.35 LINK C MLE F 10 N ALA F 11 1555 1555 1.33 LINK C DAL H 1 N MLE H 2 1555 1555 1.34 LINK N DAL H 1 C ALA H 11 1555 1555 1.33 LINK C MLE H 2 N MLE H 3 1555 1555 1.35 LINK C MLE H 3 N MVA H 4 1555 1555 1.34 LINK C MVA H 4 N BMT H 5 1555 1555 1.36 LINK C BMT H 5 N ABA H 6 1555 1555 1.33 LINK C ABA H 6 N SAR H 7 1555 1555 1.34 LINK C SAR H 7 N MLE H 8 1555 1555 1.34 LINK C MLE H 8 N VAL H 9 1555 1555 1.33 LINK C VAL H 9 N MLE H 10 1555 1555 1.35 LINK C MLE H 10 N ALA H 11 1555 1555 1.33 CRYST1 60.300 74.000 97.900 90.00 90.00 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 15.07500 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016584 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013514 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010215 0.00000